These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 16698685

  • 1. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
    Watanabe N, Narita M, Yokoyama A, Sekiguchi A, Saito A, Tochiki N, Furukawa T, Toba K, Aizawa Y, Takahashi M.
    Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
    [Abstract] [Full Text] [Related]

  • 2. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [Abstract] [Full Text] [Related]

  • 3. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2.
    Li W, Kubo S, Okuda A, Yamamoto H, Ueda H, Tanaka T, Nakamura H, Yamanishi H, Terada N, Okamura H.
    J Immunother; 2010 Apr; 33(3):287-96. PubMed ID: 20445349
    [Abstract] [Full Text] [Related]

  • 6. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
    Iwasaki M, Tanaka Y, Kobayashi H, Murata-Hirai K, Miyabe H, Sugie T, Toi M, Minato N.
    Eur J Immunol; 2011 Feb; 41(2):345-55. PubMed ID: 21268005
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of type I IFNs on the growth of WC1- CD8+ gamma delta T cells and WC1+ CD8- gamma delta T cells in vitro.
    Tuo W, Bazer FW, Davis WC, Zhu D, Brown WC.
    J Immunol; 1999 Jan 01; 162(1):245-53. PubMed ID: 9886392
    [Abstract] [Full Text] [Related]

  • 12. Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.
    Nussbaumer O, Gruenbacher G, Gander H, Komuczki J, Rahm A, Thurnher M.
    J Immunol; 2013 Aug 01; 191(3):1346-55. PubMed ID: 23794630
    [Abstract] [Full Text] [Related]

  • 13. In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.
    Burjanadzé M, Condomines M, Reme T, Quittet P, Latry P, Lugagne C, Romagne F, Morel Y, Rossi JF, Klein B, Lu ZY.
    Br J Haematol; 2007 Oct 01; 139(2):206-16. PubMed ID: 17897296
    [Abstract] [Full Text] [Related]

  • 14. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.
    Kunzmann V, Kretzschmar E, Herrmann T, Wilhelm M.
    Immunology; 2004 Jul 01; 112(3):369-77. PubMed ID: 15196204
    [Abstract] [Full Text] [Related]

  • 15. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M, Tanaka Y, Yagi J, Uchiyama T, Ogawa K.
    Anticancer Res; 2008 Jul 01; 28(5B):2921-31. PubMed ID: 19031935
    [Abstract] [Full Text] [Related]

  • 16. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.
    Haas JD, González FH, Schmitz S, Chennupati V, Föhse L, Kremmer E, Förster R, Prinz I.
    Eur J Immunol; 2009 Dec 01; 39(12):3488-97. PubMed ID: 19830744
    [Abstract] [Full Text] [Related]

  • 17. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
    Moens E, Brouwer M, Dimova T, Goldman M, Willems F, Vermijlen D.
    J Leukoc Biol; 2011 May 01; 89(5):743-52. PubMed ID: 21330350
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of innate immunity by IL-18.
    Li W, Yamamoto H, Kubo S, Okamura H.
    J Reprod Immunol; 2009 Dec 01; 83(1-2):101-5. PubMed ID: 19853308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.